NEW YORK, May 10 (GenomeWeb News) - Fisher Scientific yesterday reported 3-percent year-over-year organic revenue growth in the first quarter, amid overall revenue growth of 35 percent.
Fisher's total revenues for the first quarter increased to $1.35 billion from $1 billion in the same period in 2004. Excluding foreign currency exchange benefits, the company's Q1 sales were $1.34 billion.
Revenues from scientific products and services excluding foreign currency benefits increased 31 percent to $970.7 million. However, the company said that approximately 2 percent of this revenue growth was organic.
For healthcare products and services, Fisher reported sales of $335.8 million after foreign currency benefits, up 48 percent from the prior year's quarter. However, approximately 5 percent of this increase was organic, according to Fisher.
Fisher's revenues for its laboratory-workstations segment increased 21 percent to $46.3 million. Fisher did not break out organic growth for this segment.
The company's Q1 net income increased to $77 million, or $.64 per basic share, from $34.6 million, or $.54 per basic share in the first quarter last year.
As of March 31, Fisher had $237 million in cash and cash equivalents on hand.